BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28044310)

  • 21. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
    Basilio-de-Oliveira RP; Pannain VL
    World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of successful detection of disseminated gastrointestinal stromal tumors by ascites smear cytology using cell block preparation with DOG1 immunostaining.
    Tajima S; Kawabe A; Nagasaka K; Oda K; Kawana K; Fukayama M
    Diagn Cytopathol; 2016 Feb; 44(2):137-40. PubMed ID: 26646159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours.
    Novelli M; Rossi S; Rodriguez-Justo M; Taniere P; Seddon B; Toffolatti L; Sartor C; Hogendoorn PC; Sciot R; Van Glabbeke M; Verweij J; Blay JY; Hohenberger P; Flanagan A; Dei Tos AP
    Histopathology; 2010 Aug; 57(2):259-70. PubMed ID: 20716168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Old and new immunohistochemical markers for the diagnosis of gastrointestinal stromal tumors.
    González-Cámpora R; Delgado MD; Amate AH; Gallardo SP; León MS; Beltrán AL
    Anal Quant Cytol Histol; 2011 Feb; 33(1):1-11. PubMed ID: 22125840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovered on gastrointestinal stromal tumor 1, a keystone in the diagnosis of extraintestinal gastrointestinal stromal tumors.
    Sahu KK; Tapadia R; Kini JR; Pai RR; Kini H; Nirupama M; Pooja KS
    J Cancer Res Ther; 2019; 15(1):138-141. PubMed ID: 30880769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Gastrointestinal stromal tumors (GISTs): clinical and pathological features].
    Kovács M; Nagy P; Pák G; Fehér J
    Orv Hetil; 2005 Jun; 146(26):1375-81. PubMed ID: 16052979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of biologic potential and risk stratification for predicting disease-free survival after resection of primary gastrointestinal stromal tumor: A multivariate clinicopathological study.
    Vij M; Agrawal V; Kumar A; Pandey R
    Indian J Cancer; 2015; 52(3):351-7. PubMed ID: 26905135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
    Can B; Sökmensüer C
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CLINICOPATHOLOGICAL AND IMMUNO-HISTOCHEMICAL CHARACTERIZATION OF GASTROINTESTINAL STROMAL TUMOUR AT FOUR TERTIARY HEALTH CENTERS IN NIGERIA USING CD117, DOG1, AND HER-2 BIOMARKERS.
    Rasheed MW; Afolayan EA; Uchechukwu BE; Najeem AI; Kabiru A; Adegboye AT; Oluogun WA; Adekunle AA
    West Afr J Med; 2023 Nov; 40(11 Suppl 1):S25. PubMed ID: 37978874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases.
    Yamamoto H; Kojima A; Nagata S; Tomita Y; Takahashi S; Oda Y
    Am J Surg Pathol; 2011 Sep; 35(9):1287-95. PubMed ID: 21836495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors.
    Espinosa I; Lee CH; Kim MK; Rouse BT; Subramanian S; Montgomery K; Varma S; Corless CL; Heinrich MC; Smith KS; Wang Z; Rubin B; Nielsen TO; Seitz RS; Ross DT; West RB; Cleary ML; van de Rijn M
    Am J Surg Pathol; 2008 Feb; 32(2):210-8. PubMed ID: 18223323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status.
    West RB; Corless CL; Chen X; Rubin BP; Subramanian S; Montgomery K; Zhu S; Ball CA; Nielsen TO; Patel R; Goldblum JR; Brown PO; Heinrich MC; van de Rijn M
    Am J Pathol; 2004 Jul; 165(1):107-13. PubMed ID: 15215166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovered on gastrointestinal stromal tumour 1 (DOG1): a useful immunohistochemical marker for diagnosing chondroblastoma.
    Akpalo H; Lange C; Zustin J
    Histopathology; 2012 Jun; 60(7):1099-106. PubMed ID: 22335248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastrointestinal Stromal Tumors: A Clinicopathological and Immunohistochemical Study of 65 Cases.
    Tepeoğlu M; Özgün G; Tunca MZ; Tezcaner T; Özdemir BH
    Turk Patoloji Derg; 2018; 34(3):207-214. PubMed ID: 29630088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histopathological Features of Gastrointestinal Stromal Tumors and the Contribution of DOG1 Expression to the Diagnosis.
    Güler B; Özyılmaz F; Tokuç B; Can N; Taştekin E
    Balkan Med J; 2015 Oct; 32(4):388-96. PubMed ID: 26740899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
    Miettinen M; Wang ZF; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis.
    Wang CJ; Zhang ZZ; Xu J; Wang M; Zhao WY; Tu L; Zhuang C; Liu Q; Shen YY; Cao H; Zhang ZG
    World J Gastroenterol; 2015 Jul; 21(27):8398-407. PubMed ID: 26217092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
    Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
    Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological and immunohistochemical characterization of gastrointestinal stromal tumour at four tertiary health centers in Nigeria using CD117, DOG1, and human epidermal growth factor receptor-2 biomarkers.
    Rasheed MW; Abiodun AE; Eziagu UB; Idowu NA; Kabiru A; Adegboye TA; Oluogun WA; Ayoade AA
    Ann Afr Med; 2023; 22(4):501-507. PubMed ID: 38358152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological features of primary leiomyosarcoma of the gastrointestinal tract following recognition of gastrointestinal stromal tumours.
    Yamamoto H; Handa M; Tobo T; Setsu N; Fujita K; Oshiro Y; Mihara Y; Yoshikawa Y; Oda Y
    Histopathology; 2013 Aug; 63(2):194-207. PubMed ID: 23763337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.